TaskUs’ Post

Lots of conversations on "being direct" with patients; however, it is important to be clear on the two distinctions of these models: 1) Connecting patients to specialists/potential treaters is not entirely new. Many specialty product websites provide direct link to respective specialists based on patient geography; however, providing/facilitating telehealth appointments with doctors is relatively new. 2) The more disruptive practice is circumventing traditional distributors (wholesalers, pharmacies) and working with Amazons and Mark Cubans of the world to provide direct and cost-effective drug delivery. Overlaid on direct distribution models is decision to go cash pay (patient pays OOP) or use traditional PBMs or work with smaller/emerging PBMs who claim to offer greater transparency. Multiple factors evolving in the access landscape are going to converge at some point and GLP-1s may be just the starting point for these "experiments"

The landscape of patient care is evolving rapidly, and virtual care is at the forefront of this revolution! 🚀 Did you know that access to virtual care is making a profound impact on patient support, especially in critical therapy areas like GI and respiratory health? 🩺 Pharmaceutical companies have a golden opportunity to stand out in the competitive market, by embracing virtual care solutions.💡 Curious to learn how? 🤔 Click here to discover the secrets of leveraging virtual care for differentiation and driving better patient outcomes 👉 https://lnkd.in/eQjz7PVU #Healthcare #VirtualCare #PatientCare #PatientCentricity #PatientExperience #Homecare #NHS

The landscape of patient care is evolving rapidly, and virtual care is at the forefront of this revolution! 🚀 Did you know that access to virtual care is making a profound impact on patient support, especially in critical therapy areas like GI and respiratory health? 🩺 Pharmaceutical companies have a golden opportunity to stand out in the competitive market, by embracing virtual care solutions.💡 Curious to learn how? 🤔 Click here to discover the secrets of leveraging virtual care for differentiation and driving better patient outcomes 👉 https://lnkd.in/eQjz7PVU #Healthcare #VirtualCare #PatientCare #PatientCentricity #PatientExperience #Homecare #NHS

Achieving health means more than just staying disease-free; it's about flourishing in every aspect of our lives. 🌱 This quote reminds us to prioritize not just our bodies but our minds and relationships too. 🧘♂️💖 How do you maintain balance in your life? 🩺 Medcare Pharma: Your Way to Cure Contact us: ☎️ | 1-866-4-MEDICINE 📧 | info@medcarepharma.care 🌐 | https://lnkd.in/gA9pPUVR #clinicaltrial #clinicalresearch #medicalresearch #clinicalstudies #clinicalstudy #healthcare #medcarepharma #researchstudies

Great article from Gary Mooney

Developing a comprehensive pricing strategy for insulin is a critical step in addressing affordability and adherence issues faced by patients. A recent survey of top endocrinologists and cardiologists reveals that physician prescription criteria extend beyond price to include efficacy, tolerability/side effects, frequency of usage, drug composition, and administrative form, based on their interactions with patients. To ensure the pricing model is all-encompassing and takes into consideration the broader spectrum of patient and physician needs, an algorithm incorporating these diverse factors will be developed. The proposed price modeling strategy aims to significantly reduce the price of insulin by taking a holistic approach that considers a wide range of factors influencing the patient journey and prescription decisions. Continuous monitoring and evaluation of the pricing model's impact on insulin affordability and patient adherence will be essential. Let's work together to make insulin more affordable and accessible for all who need it. #insulinaffordability #patientadherence #healthcarepricing #healthcareaccessibility

The landscape of patient care is evolving rapidly, and virtual care is at the forefront of this revolution! 🚀 Did you know that access to virtual care is making a profound impact on patient support, especially in critical therapy areas like GI and respiratory health? 🩺 Pharmaceutical companies have a golden opportunity to stand out in the competitive market, by embracing virtual care solutions.💡 Curious to learn how? 🤔 Click here to discover the secrets of leveraging virtual care for differentiation and driving better patient outcomes 👉 https://lnkd.in/eQjz7PVU #Healthcare #VirtualCare #PatientCare #PatientCentricity #PatientSafety #PatientExperience #Homecare #NHS

On November 1, CMS finalized two policies that aim to help medtech solutions gain ground in these drug-dominated fields. One key strategy for expanding #medtech markets is creating devices that provide a safer or more targeted alternative to traditional drug therapies. However, reimbursement policies, which often favor established treatment methods, can hinder this transition in areas where drugs have long been the standard approach. These policies—one focused on addressing the opioid crisis and the other on enhancing #mentalhealth care—were included in extensive Medicare rulemaking documents that set new payment rates and frameworks for much of the healthcare system in the coming year. CMS published its 2025 payment rules November 1, including some positive policies for pain management #medicaldevices and prescription digital therapeutics for mental health: https://bit.ly/48Ilmdo

We all know Rx costs are soaring and not coming down anytime soon. And now a new study shows that 92% of employers are concerned about high-cost drugs in the pipeline, with 91% reporting concern about pharmacy cost trends overall. No surprise there, but certainly not good news for our HR and Finance executives that need to manage these rising costs and their employees' expectations. If this describes you, please know that there are multiple ways to take back some control over your pharmacy spend, whether you're a fully insured group or a self-funded organization... https://lnkd.in/gsBfshNv

HEALTHCARE: Generic drugs present a notable absence of consensus among physicians within the realm of healthcare regarding patients’ choice between branded and generic alternatives. https://lnkd.in/g_E2efUD #genericdrugs #brandeddrugs #healthcare #physicians #health #patients #doctors #biovoicenews